Dr. Michael Thormann
Dr. Michael Thormann

Dr. Michael Thormann

CEO & CSO, Origenis

Day2, July 6, 12:30 p.m., Session B:
The bavarian therapeutic strategy to combat the COVID 19 pandemic

Michael Thormann is co-founder of Origenis and co-inventor of MOREsystem® and MolMind®. He leads the technology platform development, implementation, and its application throughout the drug discovery and development process. As CSO, he is responsible for the success of the cross-functional, highly interdisciplinary team and empowers scientific excellence and technological leadership, and industrial applicability. Prior Origenis, as Head of Molecular Modeling at Morphochem, he invented protein- and ligand-based drug design methods, QSPR, parallel evolutionary search algorithms, and multiparametric optimization techniques, that together with Cippix® and BRAINstorm® have lead to Origenis’ proprietary AI Innovation Platform.